We look forward to presenting important new data for Afrezza at this year’s ATTD and contributing to the scientific dialogue around meal-time diabetes management across both adult and pediatric ...
Researchers conduct the first meta-analysis comparing hypnotics in OSA patients, finding most are safe but flagging temazepam ...
Most hypnotics (sleep medications) for insomnia (sleep disorder) do not worsen obstructive sleep apnea but emphasize the need ...
Management prioritizes 5%–10% weight loss and acetazolamide titration guided by Frisén grading, OCT, and visual fields; refractory or vision-threatening disease may need ONSF or CSF shunting.
Obstructive sleep apnea (OSA) is a common sleep disorder characterized by oxygen desaturation due to repeated airway collapse ...
Although tolvaptan bests fluid restriction at raising plasma sodium concentration, 19% of patients experience overcorrection ...
Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...
Altimmune, Inc. (NASDAQ:ALT) Q4 2025 Earnings Call Transcript March 5, 2026 Altimmune, Inc. misses on earnings expectations. Reported EPS is $-0.27191 EPS, expectations were $-0.25. Operator: Good ...
Medication can significantly improve the ability to initiate tasks, sustain attention, and complete responsibilities”— ...
Trauma healing shouldn't be a solo battle. Explore a three-level map: inner parts, relationships, and meaning, to know when to process and how integration unfolds.
Xenon Pharmaceuticals (XENE) stock soared 40% after Phase 3 trial data for azetukalner exceeded expectations in focal onset seizures. FDA filing set for Q3 2026.
The Hoffman Process, popular with a growing number of CEOs and celebrities, is often described as ‘10 years of therapy in a week.’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results